Endothelin mediated contraction of equine laminar veins.

This research investigates the role of Endothelin-1 (ET-1), a peptide that can affect blood vessels, in the veins of horses and ponies. The aim is to understand how ET-1 contributes to the development of laminitis, a painful and debilitating hoof disease, in the broader context of the microcirculation in the equine foot.

Research Methodology

• This study investigated small veins in the digital laminae region of the foot from healthy horses and ponies. These were obtained from animals euthanized at an abattoir.
• Using wire myography, a technique for examining small blood vessels, the researchers analyzed the veins’ responses to ET-1 and various other agents.
• They created concentration-response curves for ET-1 in the presence of two ETA and ETB receptor antagonists (BQ123 and BQ788), and L-NAME, an inhibitor of nitric oxide synthesis.
• The researchers also studied BQ3020, a compound that selectively activates ETB receptors. They observed its effects alone and after treatment with L-NAME, with or without BQ788.

Research Findings

• The results showed that the contraction of laminar veins caused by ET-1 was significantly blocked by BQ123 but not BQ788. This indicates an important role of ETA receptors in the veins’ reaction to ET-1.
• When L-NAME was present, the veins’ sensitivity to ET-1 increased fourfold, and addition of BQ788 did not alter the heightened sensitivity. This suggests the role of nitric oxide in modulating ET-1’s effects.
• BQ3020 by itself had no venoconstrictive effect. But when combined with L-NAME, it caused venous contraction with about 30% of the efficacy of ET-1. This reaction was prevented by BQ788, signifying the involvement of ETB receptors on both the vascular endothelium and the smooth muscle of the veins.

Conclusions

• Overall, the study provides important insights into the roles of ETA and ETB receptors in the response of equine laminar veins to ET-1. The findings also suggest the opposing yet nearly equal roles of ET-1 receptors located at different parts of the vein.
• These findings justify further investigation of ET-1 receptors in horses suffering from laminitis, in the hope of gleaning more information on this disease’s underpinnings and pave the way for development of effective treatments.